"We Receive and Publish"
Site editing
Policlinico di Palermo resolution.pdf(228720 bytes)
Regulation of the Sicilian Region of scientific information on drugs of 20 June 2006.pdf(81000
Dear friends and readers of this site, I have recently read on the web the request for clarification of the colleague Luca C. who says so in his letter "Today I learned of the new provisions that the general director of the Giaccone polyclinic in Palermo has imposed on all departments, I am attaching one copy. Do you have any advice about this? Who can write an official letter to reply to the director general? Thanks in advance for any response."
And the relative comment of the director of this magazine and I was therefore truly amazed by the great ignorance that reigns supreme in our sector and the ease with which people now far from the dynamics of work give advice or clarifications that are very often erroneous if not downright misleading. In particular, the letter - request of the colleague receives a response that is both misleading and incorrect, in fact in the response article in question, it is an article and a regional legislation already largely outdated. In fact, in the month of July 2006 and in particular on 28 July 2006, the Sicily Region published in its Official Gazette a new version and draft of the regulation of scientific drug information which replaced the previous one. (see pdf attachment). In it at point 2 it reads as follows:
"2) Carrying out the activity of the ISFs, within the structures of the SSR, including those accredited, is ensured and facilitated by the health directorates, also making use of the collaboration of the company pharmaceutical services and the hospital pharmacies of the aforementioned structures, through the identification of suitable premises (example: doctors' room, ward library, doctor's office), in time slots agreed with the head of the operating unit. The aforementioned methods must be visibly advertised at the entrance to the facility. In order to sensitize doctors, pharmacists and healthcare professionals to share a company policy scheduling scientific information meetings on drugs, or through individual visits preferably by appointment or through collective meetings organized by the directorates themselves and/or by the heads of the OUs, the medical director will be the guarantor of the process. Therefore, the performance of medical-scientific information activities will not be permitted in inpatient wards as well as in specialist outpatient clinics
